| Video
Dr. Nick Knezevic, clinical professor of Anesthesiology and Surgery at University of Illinois in Chicago, offers some potential treatments for treatment resistant headaches.
| Article
Over 35 clinical studies from journal articles and meta-analyses were included in a literature review of chronic migraine’s impact on the quality of sleep. In the journal of Nature and Science of Sleep, common sleep disturbances were analyzed to determine the relationship to chronic migraine.
| Article
A qualitative study in the Headache journal asked children and their caregivers about treatment preferences regarding migraine. Although soliciting opinions from those involved in treatments is valuable, too little research has been done to find out what matters most. Via stratified purposive...
| Article
“…patients in racial and ethnic minority groups have a 60% increased risk of experiencing severe postpartum pain and are 20% less likely to receive opioids for postpartum pain” than non-Hispanic White women. That disparity is being addressed in an article in JAMA Network Open, specifically the use...
| Article
Headache disorders “are among the most prevalent and disabling conditions worldwide,” according to the Global Burden of Disease (GBD) study. A review in The Journal of Headache and Pain identified over 350 relevant published papers. Among the findings are the percent of the population with:
- Activ...
| Article
The question posed in an article published in Annals of Internal Medicine: have patients suffering from chronic noncancer pain been affected negatively by state laws curbing opioid prescribing? There have been a few overlapping laws, for prescribing caps, pill mills, enrollment, and mandatory...
| Article
The Journal of Clinical Medicine has published an article: Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data. Researchers identified headache disorders—including migraine, tension-type headache...
| Article
Some think e-cigarettes are safer than the “real” thing. For those who have COVID, however, users of e-cigarettes are more likely to experience symptoms at a higher frequency. About the study published in Journal of Primary Care & Community Health, coauthor David McFadden, MD, a Mayo Clinic...
| Article
JAMA Neurology reports findings gathered from over 2600 migraine sufferers, aged 18 to 65, from 4 randomized clinical trials. Researchers sought to determine whether erenumab would improve migraine frequency and lessen migraine medication need in those with and without aura. The study notes, “One or...
| Article
A study published in Frontiers of Pain Research utilized data from almost 52,000 participants in the Swedish Twin Registry to better understand migraine and genetic and environmental factors. Migraine affects approximately 1 in 7 people, is the 2nd largest cause of disability, and 3 times as many...